Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

1.39
Delayed Data
As of Nov 21
 -0.1099 / -7.33%
Today’s Change
1.39
Today|||52-Week Range
4.64
-26.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$22.1M

Company Description

Fibrocell Science, Inc. operates as an autologous cell therapy company, which engages in the development of treatments for skin and connective tissue diseases with unmet medical needs. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company was founded on September 1, 2009 and is headquartered in Exton, PA.

Contact Information

Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 713-6000
Investor Relations:
(484) 713-6133

Employees

Shareholders

Mutual fund holders6.74%
Other institutional11.23%
Individual stakeholders0.05%

Top Executives

John M. MaslowskiPresident, CEO, CFO & Director
Sean D. BuckleySecretary & Vice President-Business Administration
Lisa A. EmbonVice President-Corporate Accounting & Controller
Karen CaseyInvestor & Media Relations Contact
Pamela A. SwiggardVP-Regulatory Affairs & Quality Assurance